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In orally acquired bacteria, the ability to counteract extreme acid stress (pH 6 2.5) ensures survival
during transit through the animal host stomach. In several neutralophilic bacteria, the glutamate-
dependent acid resistance system (GDAR) is the most efﬁcient molecular system in conferring
protection from acid stress. In Escherichia coli its structural components are either of the two
glutamate decarboxylase isoforms (GadA, GadB) and the antiporter, GadC, which imports glutamate
and exports c-aminobutyrate, the decarboxylation product. The system works by consuming
protons intracellularly, as part of the decarboxylation reaction, and exporting positive charges via
the antiporter.
Herein, biochemical and spectroscopic properties of GadB from Brucella microti (BmGadB), a
Brucella species which possesses GDAR, are described. B.microti belongs to a group of lately described
and atypical brucellae that possess functional gadB and gadC genes, unlike the most well-known
‘‘classical’’ Brucella species, which include important human pathogens. BmGadB is hexameric at
acidic pH. The pH-dependent spectroscopic properties and activity proﬁle, combined with in silico
sequence comparison with E. coli GadB (EcGadB), suggest that BmGadB has the necessary structural
requirements for the binding of activating chloride ions at acidic pH and for the closure of its active
site at neutral pH. On the contrary, cellular localization analysis, corroborated by sequence inspec-
tion, suggests that BmGadB does not undergo membrane recruitment at acidic pH, which was
observed in EcGadB. The comparison of GadB from evolutionary distant microorganisms suggests
that for this enzyme to be functional in GDAR some structural features must be preserved.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In several food-borne pathogens and orally acquired bacteria,
such as Escherichia coli, Shigella ﬂexneri, Listeria monocytogenes
and Lactoccoccus lactis, the glutamate-dependent acid resistance
system (GDAR) is the most efﬁcient system in counteracting the
extreme acid stress encountered by these microorganisms duringtheir transit through the mammalian host stomach [1,2]. GDAR
relies on the activities of an enzyme, glutamate decarboxylase
(Gad; EC 4.1.1.15), and an antiporter (GadC) (Fig. 1). In E. coli,
GDAR was extensively studied [1]. Following a drop of the
extracellular pH to 2.5 or lower, (i) the cytoplasm becomes acidic
(pH 6 5.0) because the cell membrane becomes leaky to protons
(H+); (ii) the intracellular acidiﬁcation activates Gad, which at each
catalytic cycle consumes an intracellular H+ while converting
L-glutamate (L-Glu) into c-aminobutyrate (GABA); (iii) the pro-
ton-consuming activity of Gad is coupled to the electrogenic anti-
port carried out at this same pH values by GadC, which provides to
the L-Glu0/GABA+1 antiport [3,4]. Thus, by consuming H+ and
exporting positive charges, the decarboxylase and the antiporter
make up an efﬁcient molecular system which protects the bacteria
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Fig. 1. Schematic representation of the role played by the major structural components of the E. coli GDAR system, the most extensively investigated AR system [1].
L-glutamate (L-Glu, net charge 0) is taken up by the electrogenic L-Glu0/GABA+1 antiporter GadC, an inner membrane protein. Decarboxylation of L-Glu via GadA/B consumes
an intracellular H+ at each catalytic cycle, while GadC contributes to the generation of proton motive force by GABA (net charge +1) export. The structures of GadB at acidic pH
(PDB: 1PMM) and GadC at pH 8.0 (PDB: 4DJK), the only one currently available, are shown as ribbon drawing generated with PyMol. The C-plug that in GadC is locking the
substrate entry channel is shown in ﬁlled space.
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structural bases underlying GadB and GadC activities in E. coli have
been unveiled and share striking similarities [5,6]. Both proteins
undergo auto-inhibition at pH >5.5: GadB uses a 15 amino
acid-long C-terminal tail to plug the access to the active site [5],
whereas GadC engages the last 41 amino acids residues in its
sequence, localized on the cytoplasmic side of the inner mem-
brane, to lock the substrate entry channel [6] (Fig. 1). Notably, in
both proteins these structural elements contain histidine residues
playing a crucial role as gate-keepers.
While E. coli possesses one copy of the GadC coding gene (gadC)
and two genes (gadA and gadB) coding for the glutamate decar-
boxylase isoforms, GadA and GadB, many bacteria possess only
one decarboxylase-coding gene (gadB) and one antiporter-coding
gene (gadC), nonetheless they still display GDAR [1]. Amongst
them, there is Brucella microti CCM4915, an environment-borne
pathogenic Brucella species isolated from common vole [7], red
fox [8] and soil [9], as well as several recently described, atypical
Brucella species (Brucella inopinata BO1 and B. inopinata-like BO2
isolated from humans, Brucella spp. from African frogs) [10–12]
and brucellae isolated from marine mammals (Brucella ceti and
Brucella pinnipedialis).
The gadB and gadC genes of B. microti were recently shown to
participate in GDAR [13]: they play an essential role in GDAR
in vitro and contribute to the survival of B. microti in a murine
model of infection following oral inoculation. More recently, also
the lately described brucellae and those from marine mammals
were shown to possess GDAR, unlike the most well-known ‘‘classi-
cal’’ terrestrial Brucella species pathogenic for livestock,
domesticated animals and man (i.e. Brucella melitensis, Brucellaabortus, Brucella suis, Brucella canis and Brucella ovis) [14]. In the
‘‘classical’’ terrestrial species gadB and/or gadC genes are in fact
inactivated by stop codons and/or frameshift mutations [15] and
therefore the GDAR system was found to be not functional [14].
The reason for these genotypic differences is still unclear, though
it might be related to a speciﬁc adaptation of each Brucella
strain/species to a different environment and to stresses encoun-
tered during its lifecycle [14]. This is clearly an interesting aspect
if one considers that the World Health Organization has estimated
brucellosis as the most widespread bacterial zoonosis [16].
Prompted by (i) the ﬁnding that in B. microti and many other
Brucella species GadB participates in GDAR [13,14] and (ii) the
new knowledge on the mechanisms controlling the intracellular
activity and cellular localization of EcGadB [5,17,18], a detailed bio-
chemical characterization of B. microti GadB (BmGadB) was under-
taken. BmGadB shares with E. coli GadB (EcGadB) 73% sequence
identity, including a set of strictly conserved residues which are
known to occupy critical positions, i.e. in the active site or at sites
where pH-dependent conformational changes occur in EcGadB [1].
In the last decade it was shown that these conformational changes
in EcGadB can be clearly monitored spectroscopically and by cellu-
lar localization analysis of the protein [5,17,18], thereby avoiding
the need to set up more laborious crystallographic investigations.
Therefore in this work the kinetic and spectroscopic properties of
recombinant BmGadB were compared with those of the thoroughly
characterized EcGadB. Overall, our study demonstrates that GadBs
from evolutionary distant microorganisms, such as E. coli (a
Gammaproteobacterium) and B. microti (an Alphaprotebacterium),
share many biochemical properties and structural features which
are instrumental for the full development of GDAR.
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2.1. Materials
FastStart High Fidelity PCR system, restriction enzymes, calf
intestine alkaline phosphatase, DNA ligation system and ampicillin
were from Roche Applied Sciences. StrataClone™ PCR Cloning Kit
was from Stratagene. Taq DNA polymerase for colony PCR was from
GeneSpin (Milano, Italy). Nucleospin plasmid and Nucleospin gel
and PCR clean-up kits were from Macherey–Nagel. Unstained
Protein Molecular Weight Marker for SDS–PAGE was from
Thermo Scientiﬁc. Ingredients for bacterial growth were from
Difco. Streptomycin sulfate was from U.S. Biochemical Corp.
(Cleveland, OH, USA). DEAE Sepharose FF was from GE
Healthcare Life Sciences. PLP and analytical grade sodium acetate
were from VWR International. Sodium chloride was from Riedel-
de-Haen. Vitamin B6, potassium dihydrogen phosphate, dipotas-
sium hydrogen phosphate, L-glutamic acid, sodium glutamate
and kanamycin were from Fluka. All other chemicals were from
Sigma–Aldrich. Oligonucleotide synthesis was by MWG Biotech.
2.2. N-terminal sequence determination
The medium-copy-number plasmid pBBR1MCS-gadBC (B. microti),
consisting of the cloning vector pBBR1MCS carrying a 3.52 kb
genome fragment encompassing the whole B. microti gadBC operon
inclusive of its indigenous promoter [13], was used to transform
the E. coli strain CC118, which displays extremely low levels of
Gad [14], as based on the qualitative GAD test [19] and the
quantitative Gad activity assay [20]. Preliminary analysis on the
expression and functionality of BmGadB was performed. Brieﬂy, a
50-ml culture was grown overnight (i.e. 18 h) in LB broth at
37 C. Bacterial cells were collected by centrifugation at
3500 rpm, resuspended in 1 ml of an aqueous solution containing
1 mM PLP/1 mM DTT and disrupted by sonication. The clariﬁed
supernatant was subjected to western blotting and Gad activity
assay [20,21]. As control, the E. coli strain CC118 carrying the
empty plasmid pBBR1MCS was analyzed in parallel. Due to the sig-
niﬁcant degree of protein identity (73%), BmGadB is recognized by
the anti-EcGadB antibodies [21]. Using the same protocol described
for EcGadB [20], BmGadB was puriﬁed to approx. 50% purity from
E. coli CC118/pBBR1MCS-gadBC (B. microti) strain. An 11 lg aliquot
of partially puriﬁed BmGadB (corresponding to approx. 5 lg of
pure BmGadB) was subjected to SDS–PAGE [22] followed by
blotting onto polyvinylidine diﬂuoride (PVDF) membrane. The area
of the PVDF membrane corresponding to BmGadB was excised and
subjected to N-terminal sequencing (Proteome Factory AG, Berlin,
Germany).
2.3. Cloning strategy
The B. microti gadB ORF (i.e. starting from the ATG codon iden-
tiﬁed by N-terminal sequencing) was ampliﬁed using the FastStart
High Fidelity PCR system with pBBR1MCS-gadBC (B. microti) as
template and the oligonucleotide pair 50-GGCATATGACTGGTTCA
AACTATCCG-30 and 50-GGGGATCCTTATGTGTGGTGAAAGCCG-30
designed to anneal over the start and the stop codons, respectively.
The italicized sequences indicate the NdeI and BamHI restriction
sites used for directional cloning of the PCR product into the
corresponding sites of the pET3a expression vector (Novagen).
The PCR product was initially cloned into the pSC-A vector
(StrataClone PCR Cloning Kit). E. coli StrataClone SoloPack transfor-
mants were selected by blue/white screening. Plasmids from white
colonies were puriﬁed and fully sequenced on both strands tocheck for any unwanted mutation. Plasmid pSC-A_Bm-gadB was
doubly digested with NdeI and BamHI and the resulting 1395-bp
DNA fragment, corresponding to the whole B. microti gadB ORF,
was subcloned into pET3a, previously digested with the same
restriction enzymes. The newly generated plasmid pET3a_
Bm-gadB was used to transform E. coli strain DH5a.
Transformants were screened for the presence of the insert, ini-
tially by colony PCR and then by digestion with NdeI and BamHI.
For protein expression and puriﬁcation, the plasmid construct
pET3a_Bm-gadB was transferred into the E. coli strain BL21(DE3),
a Gad-negative strain as based on qualitative GAD test [19] and
the quantitative Gad activity assay [20].
2.4. Protein puriﬁcation, SDS–PAGE and cell fractionation
The conditions used for over-expression and puriﬁcation of
BmGadB were essentially as described for EcGadB [20], except that
bacteria were grown in LB broth containing 0.5% glucose, induced
with 1 mM IPTG and that the DEAE ion-exchange chromatography
step was carried out on a smaller-sized column (2.1 cm  20 cm).
Protein purity was assessed by 12% SDS–PAGE [22]. Enzyme con-
centration and activity were assayed as previously described
[20]. The PLP content was determined by releasing it from GadB
with 0.1 N NaOH and measuring the absorbance at 388 nm
(e388 = 6550 L mol1 cm1) [23].
The effect of pH on the cellular localization of BmGadB was
assessed by SDS–PAGE and enzyme activity in cell extracts from
the E. coli strain BL21 (DE3)/pET3a_Bm-gadB following cell frac-
tionation, as previously described for EcGadB [18]. Brieﬂy, bacteria
were grown in 1 L of LB medium, induced with IPTG and harvested
by centrifugation at 6000 rpm for 30 min at 4 C. The bacterial cell
pellet was resuspended in 20 ml of 50 mM Tris/HCl pH 7.0,
containing 1 mM DTT and protease inhibitors, and split into two
10-ml aliquots. The two samples were brought to pH 7.2 and 5.1
for BmGadB and to pH 7.2 or 5.5 for EcGadB by addition of few
microliters of 6 N NaOH or HCl, respectively. After sonication to
achieve cell lysis, the pHs of the samples were checked again and
adjusted to the correct pH, where necessary. Cell debris was
removed by centrifugation at 5000 rpm for 20 min at 20 C.
Hence, the obtained cell supernatants were ultracentrifuged at
50,000 rpm for 1 h at 20 C to achieve an optimal separation
between the cytoplasmic (supernatant) and the membrane (pellet)
fractions, which can be separated because the membranes’ pellet is
ﬁrmly bound to the centrifugation tube and from it the super-
natant can be completely removed. Each membrane pellet, devoid
of any residual liquid phase, was then resuspended in 2 ml of
100 mM Tris/HCl pH 8.0, containing 150 mM NaCl, 5 mM EDTA
and 0.5% lauroyl sarcosine. The presence of the detergent is essen-
tial to achieve solubilization of the lipids and proteins entrapped in
this fraction. Total protein content in each sample was estimated
by Micro BCA™ protein assay (Thermo Scientiﬁc-Pierce).
2.5. Determination of molecular mass of BmGadB
The molecular mass of recombinant BmGadB was determined
by gel ﬁltration at 4 C using a Superdex 200 10/300 GL column
(GE Healthcare, Life Sciences) on an Äkta Prime FPLC system. The
mobile phase (50 mM sodium acetate buffer, pH 4.6, containing
150 mM sodium chloride) for column equilibration and protein
elution was carried out at a ﬂow rate of 0.5 ml/min. The Gel
Filtration HMW Calibration Kit (GE Healthcare, Life Sciences), with
the exclusion of thyroglobulin (outside the separation range of the
column), was used for column calibration and molecular weight
determination. 1 mg of BmGadB was loaded on column.
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The speciﬁc activity (U/mg) of BmGadB is referred to as lmol
GABA min1 mg1 [20]. The kcat and Km values were determined
at 25 C in 50 mM sodium acetate buffer, pH 4.6, containing
40 lM PLP. The Gabase assay was used to measure GABA produc-
tion at time intervals [20]. Brieﬂy, EcGadB (0.5 lg) or BmGadB
(3 lg) were incubated with 0.3–30 mM L-glutamate. The reaction
rate was determined by measuring the production of GABA in
the ﬁrst 3 min of reaction. The data collected were ﬁtted to the
standard Michaelis–Menten equation as in GraphPad Prism 4.0.
2.7. Spectroscopic measurements and data analysis
Enzyme absorption spectra were recorded at room temperature
on a Hewlett–Packard Agilent model 8453 diode array spectropho-
tometer. The buffer systems used for titrations were the follow-
ings: 50 mM sodium acetate buffer in the pH range 3.5–5.8 and
potassium phosphate buffer in the pH range 6.0–7.0.
Fluorescence excitation and emission spectra were recorded
with a FluoroMax-3 spectroﬂuorometer (Horiba Jobin–Yvon)
equipped with a thermostatically controlled cell compartment at
20 C using 5 nm bandwidth on both slits (2 nm, when excited at
295 nm) and at a scan speed of 100 nm/min. The spectra were cor-
rected by subtracting the corresponding buffer spectrum.
Curve ﬁtting and statistical analyses were carried out with
GraphPad Prism 4.0 (GraphPad Software, San Diego, CA). The pH-
dependent absorbance (Abs) changes at 420 nm and 340 nm were
analyzed using Hill equation as provided in GraphPad Prism, in
which pK is the pH at the midpoint of the spectroscopic transition
and n is the number of protons (i.e. Hill coefﬁcient) required for the
transition.
2.8. Bioinformatic analysis
Sequence alignments were performed using Clustal Omega
(http://www.ebi.ac.uk/Tools/msa/clustalo/). Secondary structure
predictions and protein parameters were obtained using resources
accessible from Expasy (http://expasy.org/proteomics).3. Results
3.1. Over-expression and puriﬁcation of BmGadB
The amino acid sequence of BmGadB from the NCBI and Patric
[24] databases differs in the N-terminal region (Fig. 2). In the
NCBI database BmGadB (NCBI: YP_003105130.1) is reported to be
6 amino acids longer at the N-terminal end than EcGadB, whereas
in the Patric database the amino acid sequence is two residues
shorter than that of EcGadB.
In order to experimentally validate the N-terminal sequence,
BmGadB were partially puriﬁed (i.e. 50% purity) following its over-
production in the E. coli strain CC118 carrying plasmid pBBR1MCS-
gadBC (B. microti). This construct consists of the cloning vector
pBBR1MCS carrying the B. microti gadBC operon [13]. The expres-
sion and functionality of BmGadB were assessed as described in
Materials and Methods. Following electroblotting onto PVDF mem-
brane, the protein band corresponding to BmGadB (5 lg; 94 pmol)
was subjected to Edman degradation and the N-terminal sequence
Met-Thr-Gly-Ser-Asn conﬁrmed that the correct N-terminal
sequence was that provided in Patric [24]. Thus mature BmGadB
consists of 464 amino acids (Fig. 2) and its molecular weight is pre-
dicted to be 52,184 Da.
Following the identiﬁcation of the correct N-terminal sequence,
plasmid pET3a_Bm-gadB was constructed and used to transformE. coli BL21(DE3), a commonly employed pET system expression
host. The choice of this host strain for the expression of BmGadB
was also based on the ﬁnding that it is GAD-negative using a qual-
itative GAD test [13,19]. At present the reason for possessing a
GAD-negative phenotype is unknown. In fact, the publicly available
genome sequence of E. coli BL21(DE3) indicate that endogenous
gadA and gadB genes are both present and intact. Thus Gad-
negative phenotype might arise either from the single nucleotide
polymorphisms detected in the promoter region of gadA (at
position 50 relative to the transcription start site) and gadB (at
position 190 relative to the transcription start site) genes or from
reduced activity/expression of the transcriptional regulators neces-
sary to trigger the expression of the GDAR system [25].
Puriﬁcation of BmGadB was carried out essentially following the
protocol used for EcGadB [20] and yielded approximately 10 mg of
soluble protein from a 2-Liter bacterial culture, even though most
of the overexpressed protein was in the form of insoluble material.
BmGadB was judged by SDS–PAGE to be 95% pure and to contain
the full complement (100%) of bound PLP.
Under the standard assay conditions used for EcGadB (50 mM
sodium glutamate in 0.2 M pyridine/HCl buffer, pH 4.6, containing
0.1 mM PLP, at 37 C), the speciﬁc activity of BmGadB was 190
Units/mg, a value close to that of the E. coli counterpart. The kcat
and Km values calculated for BmGadB are provided in Table 1.
Compared to EcGadB, Km of BmGadB is 2.4 times higher, whereas
kcat is similar, thus resulting in an enzyme with a speciﬁcity con-
stant kcat/Km halved respect to that of EcGadB.
Puriﬁed recombinant BmGadB has an apparent molecular mass
of 52 kDa as based by SDS–PAGE (data not shown) and elutes as a
307.4-kDa species by gel ﬁltration chromatography carried out at
pH 4.6 on a Superdex 200 10/300 column (Fig. 3). These results
indicate that at acidic pH, that is when the enzyme is maximally
active (see next section), BmGadB is a hexamer, alike EcGadB.
3.2. pH-dependent absorbance and activity changes
BmGadB undergoes distinct pH-dependent spectroscopic
changes in the region of the UV–visible spectrum where the PLP
cofactor absorbs (Fig. 4A), and these resemble those of EcGadB
[17]. The absorption spectra recorded in the pH range 3.5–6.5 pro-
vide evidence that the cofactor absorbance maximum abruptly
shifts from 420 nm (corresponding to the ketoenamine, active
form) to 340 nm (corresponding to the substituted aldamine, inac-
tive form) in the narrow pH range 4.4–5.2. Thus the only noticeable
difference respect to EcGadB [5,17,26] consists in the slightly more
acidic pH range at which the 420M 340 nm shift in absorbance
occurs (Table 2), though the characteristic isosbestic point of the
spectroscopic transition at 361 nm remains unaffected [17].
The titration curve generated by ﬁtting the absorbance values at
420-nm versus pH is shown in Fig. 4B and exhibits a sigmoidal
dependence which can be ﬁtted by the Hill equation. The best-ﬁt
values returned for number of protons (n) and midpoint pH (pK)
of the spectroscopic transition are given in Table 2 where
corresponding numbers for EcGadB are also provided for compari-
son. As mentioned above, the pH-dependent spectroscopic transi-
tion of BmGadB occurs at more acidic pH than EcGadB and is
complete at pH 5.5 (Fig. 4B), where the 420-nm absorbing species
becomes barely detectable (Fig. 4A). This latter observation is
indicative of an efﬁcient locking of the active site in BmGadB, a
ﬁnding substantiated by the activity assays (see below).
Chloride ions and other halides were reported to bind at allos-
teric sites in EcGadB thereby stabilizing the 420-nm, active form
[5,26]. When a similar analysis was carried out on BmGadB, it
was observed that the cofactor spectroscopic transition is similarly
affected by chloride ions (Fig. 4B): the 420-nm species persists up
to pH 5.2 and the pK of the spectroscopic transition is increased by
Fig. 2. Clustal Omega (version 1.2.1) alignment of EcGadB and BmGadB. The residues in bold blue in BmGadB correspond to the N-terminal sequence experimentally
determined by Edman degradation and on which numbering is based. The ﬁrst 8 amino acids (in italics) in BmGadB are those reported in the NCBI database (Reference
Sequence: YP_003105130.1), but absent in the protein sequence. The amino acid residues corresponding to the regions that in EcGadB undergo the most noticeable
conformational changes are red. The residues participating in halide binding in EcGadB [5] are in green background.
Table 1
Kinetic parameters of BmGadB compared to those of EcGadB.
kcat (s1) Km (mM) kcat/Km (s1 mM1)
BmGadB 17.88 ± 0.31 2.68 ± 0.17 6.66 ± 0.53
EcGadB 15.28 ± 0.58 1.10 ± 0.18 13.92 ± 2.83
The values reported were calculated using the integrated Michaelis–Menten
equation as provided in GraphPad Prism 4.0.
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vation that the residues that in EcGadB were shown to be involved
in halides binding [5] are conserved in BmGadB (Fig. 2).
To assess whether the pH dependency of the activity of BmGadB
matches that of the UV–visible spectroscopic changes, Gad activity
assays were performed in the absence/presence of sodium chloride
in the pH range 3.8–6.5. As shown in Fig. 5, BmGadB displays its
maximal activity at low pH, but only up to pH 4.5. At pH 5 the
enzyme exhibits 50% of the activity measured at pH 3.8–4.5 and
activity becomes undetectable at a pH higher than 5.6. Notably,
in the pH range 3.8–5.3 BmGadB is 1.5–3 times more active when
chloride ions are present (Fig. 5). This is similar to what is observed
with EcGadB (Fig. 5, inset), except that in EcGadB 50% of the activ-
ity is detected at pH 5.24 and 5.32, whereas that of BmGadB was
detected at pH 4.95–5.13 in the absence and presence of chloride
ions, respectively. For both proteins the data of activity versus
pH ﬁt well to the Hill equation, suggesting that cooperativity
occurs, as previously shown [17]. However a shift of 0.45 pH units
in the pK of the spectroscopic transitions observed in the presence
of chloride ions (Fig. 4B and Table 2) has not been observed on thepH at which 50% of activity is detected. In other words chloride
ions stabilize the active form of the enzyme and enhance the activ-
ity of BmGadB, but their presence does not cause a shift towards
neutral pH of the half-maximal activity value. This suggests that
the deprotonation state of active site residues is the one mostly
responsible for restricting the range of enzyme activity. A similar
observation was made for EcGadB [17].
3.3. Fluorescence properties
For EcGadB spectroﬂuorometric analysis has provided useful
insights into the chemical state of the cofactor as a function of
pH [17]. When BmGadB is excited at pH 4.0 at 430 nm, the
emission spectrum (with a maximum at 500 nm) is typical of the
ketoenamine tautomer of internal aldimine, which on the contrary
is barely detectable when the enzyme is excited at the same wave-
length but at neutral pH (Fig. 6A). These data are similar to those
reported for EcGadB [17] and, together with the UV–visible spectra,
conﬁrm that the active form of BmGadB has internal aldimine
protonated on the imine nitrogen, a pre-requisite for being cat-
alytically competent.
In order to obtain evidence on the chemical state of the inactive
enzyme form absorbing at 340 nm (Fig. 4A), the emission spectrum
of BmGadB, following excitation at either 295 nm or 345 nm, was
recorded both at acidic and near-to-neutrality pH (Fig. 6B and C).
It is important to recall here that in EcGadB His465 is responsible
for the formation of a substituted aldamine at pH >5.5 [5]. This spe-
cies emits with a maximum at 350 nm and 400 nmwhen excited at
295 nm and 345 nm, respectively [17]. Instead, the EcGadB
Fig. 3. Determination of molecular mass of BmGadB. Gel ﬁltration chromatography of BmGadB (shown as red square on the calibration curve) on a Superdex 200 10/300 GL
(GE Healthcare) column was carried out in 50 mM sodium acetate buffer, pH 4.5, containing 150 mM NaCl, at a ﬂow rate of 0.5 ml/min. HMW Calibration Kit (GE Healthcare)
included ferritin (440 kDa; a), aldolase (158 kDa; b), conalbumin (75 kDa; c), ovalbumin (44 kDa; d). 1 mg of BmGadB was loaded on the column immediately after calibration.
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Fig. 4. pH-dependent absorbance changes. (A) Absorption spectra of BmGadB were
recorded in 50 mM sodium acetate buffer at pH 3.5 (dark red), 4.2 (red), 4.5
(orange), 4.6 (magenta), 5.0 (violet), 5.4 (blue) and in 50 mM potassium phosphate
buffer at pH 6.5 (green). Spectra were normalized taking into account the full PLP
content (11.6 lM). The arrow indicates the direction of the change in absorbance at
420 nm upon pH increase. Inset: zoom of the 300–500 nm region. (B) The pH-
dependent change in absorbance at 420 nm is represented in the absence (black
squares) and presence (green squares) of 50 mM NaCl. The solid lines through the
experimental points show the theoretical curves obtained using Hill equation as in
GraphPad Prism 4.0.
Table 2
Hill parameters from curve ﬁtting of the 420 nm absorbance readings as a function of
pH.
n pK
BmGadB 3.52 ± 0.67 4.965 ± 0.028
BmGadB + 50 mM NaCl 7.52 ± 1.58 5.414 ± 0.008
EcGadB 9.64 ± 0.99 5.337 ± 0.004
EcGadB + 50 mM NaCl 7.86 ± 0.59 5.720 ± 0.005
The values reported were calculated using the integrated Hill equation.
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(Fig. 6C). This is characteristic of the enolimine tautomer of the
internal aldimine, that is the species with the hydrogen on the
phenolic oxygen more typical in a less polar environment ([17]
and references therein).
Fluorescence emission spectra recorded upon excitation either
at 295 nm (Fig. 6B) or at 345 nm (Fig. 6C) provide a clear indication
that at pH 6.5 in BmGadB a substituted aldamine is formed. In fact
the emission band at 500–510 nm is never detected (Fig. 6B and C).
3.4. pH-dependent cellular partition
In EcGadB two triple helical bundles, formed at acidic pH by the
N-terminal residues 3–15 of each subunit, were shown to be
involved in recruiting the decarboxylase to the cytosolic side of
the inner membrane, the cellular compartment where the relieving
effect from protons’ consumption was suggested to be more ben-
eﬁcial to the acid-stressed cell [5,18]. In addition these structural
elements provide proper orientation of side-chains of residues
involved in the binding of chloride ions, which act as allosteric
activators.
Secondary structure prediction tools indicate that the N-
terminal sequence of BmGadB (which contains a Pro residue at
position 7) does not support formation of a-helices. Conversely,
the same tools predict the N-terminal region of EcGadB to be able
to form a-helices and this agrees with the crystal structure data
[18]. Despite the apparent inability to form an a-helix in the N-
terminal region, BmGadB might still retain the ability to partition
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Fig. 5. Effect of pH on the activity of BmGadB. Gad activity (Units mg1) was
measured at 37 C in 50 mM sodium acetate (pH 3.8–5.8) or phosphate (pH 6.0–6.5)
buffer containing 40 lM PLP, 50 mM glutamate and in the absence (black circles) or
presence (green circles) of 50 mM NaCl. The protein concentration was 0.5–2 lM.
The solid lines through the experimental points represent the theoretical curves
obtained using Hill equation to ﬁt the data. The same experiment but with EcGadB
is shown in the inset.
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Fig. 6. Fluorescence emission spectra of BmGadB. Emission spectra were recorded
at pH 4.0 (red line) and at pH 6.5 (green line) following excitation at 430 nm (A) and
295 nm (B). (C) Emission spectra of BmGadB (black line), EcGadB (blue line) and
E. coli GadBH465A (violet line) were recorded following excitation at 345 nm at pH
6.5. The protein concentration of BmGadB was 13 lM. The protein concentration of
EcGadB and GadBH465A was 3 lM. The buffers used were 50 mM sodium acetate at
pH 4.0 and 50 mM potassium phosphate at pH 6.5.
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cytoplasmic pH. In order to address this point, cell fractionation
of the E. coli BL21(DE3) overexpressing BmGadB was carried out.
Cytoplasmic and membrane fractions at neutral pH and at pH
5.1, in the presence of chloride, were assayed for enzyme activity
and analyzed by SDS–PAGE (Fig. 7). The same analysis was carried
out on an E. coli strain overexpressing EcGadB, as previously
reported [18]. The pH 5.1 was chosen for BmGadB because at this
pH the enzyme is still in the active form (Fig. 5 and Table 2). As
predicted on the basis of the N-terminal amino acid sequence,
the cellular localization of BmGadB is not inﬂuenced by a pH
decrease, unlike that of EcGadB (Fig. 7 and [18]), thus suggesting
that in BmGadB the N-terminal region does not undergo the same
conformational changes which were reported to occur in EcGadB.
Notably, a signiﬁcant fraction of the protein (approximately 40%)
is associated to the membrane already at neutral pH and no further
recruitment to the membrane is observed when the pH of the cell
extract is lowered to 5.1.4. Discussion
After the discovery that Gad is a major structural component of
GDAR [21,27–32], only Gad from E. coliwas investigated in detail at
the spectroscopic, biochemical and structural level [5,17,18,33].
However it is becoming clear that GDAR is amongst the most
potent acid resistance systems in several neutralophilic bacteria
[1,2]: the acidic pH optimum of Gad as well as the nature of the
substrate and the product are best suited to protect bacteria from
the uncontrolled acidiﬁcation of the cytoplasm occurring upon
exposure to harsh acid stress. Thus the molecular mechanisms
underlying the control of Gad intracellular activity in different bac-
terial species is of particular interest, especially from the
evolutionary viewpoint.
In order to ﬁll this lack of knowledge, puriﬁcation and bio-
chemical characterization of recombinant GadB from B. microti
(BmGadB) was undertaken. The genus Brucella, belonging to the
class Alphaproteobacteria, consists of Gram-negative, facultative
intracellular coccobacilli, highly pathogenic for a variety of mam-
mals, including humans [16]. The twelve species of the genus are
classiﬁed on the basis of speciﬁc phenotypic traits and their natural
host preferences and grouped into ‘‘classical’’ and ‘‘newly
described, atypical’’ species, depending on the year of discovery
and description (more or less than twenty years). Humans brucel-
losis, also known as Malta fever, is essentially acquired by the oral
route, following the ingestion of non-pasteurized milk and dairy
products, but also via respiratory and conjunctival mucosae.
Thus, during their lifecycle these bacteria must cope with quite
acidic environments such as those encountered in fermented
foods, in the gastrointestinal tract of their hosts or in the intra-
cellular vacuole.
BmGadB was chosen for an in-depth biochemical and spectro-
scopic characterization because its role in B. microti GDAR has been
clearly established [13]. Moreover B. microti belongs to a group of
‘‘newly described’’ Brucella species that possess functional gadB
and gadC genes, thus distinct from the ‘‘classical’’ Brucella species
(which includes species described at least twenty years ago) in
which the same genes are not functional because of the occurrence
of stop codons and/or frameshift mutations in their ORFs [15]. In
the absence of clinical cases in humans and farm animals, the
pathogenicity of these bacteria remains unknown. However with
respect to the ‘‘classical’’ Brucella species, the newly described bru-
cellae share some characteristics such as the higher metabolic
activities, which lead to faster growth, the ability to resist better
to extreme acid stress, higher replication rates in murine and
human macrophages, and the lethality in a mouse model of
Fig. 7. pH dependent cellular partition in EcGadB (left panel) and BmGadB (right panel). 12% SDS–PAGE of 30 lg-samples of cell supernatants (S), obtained after cell lysis,
cytoplasmic (C) and membrane (M) fractions obtained as described in Section 2.4 at neutral (pH 7.2) and mildly acidic pH (pH 5.5 EcGadB or pH 5.1 BmGadB). The region of
the gel encompassing the bands corresponding to EcGadB and BmGadB is shown with a blue box. Molecular weight (kDa) standards are shown on the right of the left panel.
The decarboxylase activity is provided as percentage with respect to the corresponding starting activity in S (100%). The reported activity values represent the mean of 2–3
independent experiments, with a standard deviation not exceeding 10% of the stated value.
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stress response, it is thus noticeable that GDAR is present in
‘‘new and atypical’’ brucellae and also in several strains of B. ceti
and B. pinnipedialis isolated from marine mammals [13,14], while
absent in the terrestrial ‘‘classical’’ ones. This is apparently contra-
dictory taking into account that in humans the oral route is the
major route of infection of the ‘‘classical’’ species and that humans
are only accidental hosts. In addition, it was suggested that these
bacteria can pass into the bloodstream through the tonsils, already
before reaching the gastrointestinal tract where other acid resis-
tance factors, such as the urease enzyme, may also occur [37].
Our hypothesis is that, starting from a GAD-positive Brucella ances-
tor, this phenotypic trait was conserved in the ‘‘new and atypical’’
brucellae to increase their ﬁtness and versatility and that it was
lost in the classical highly pathogenic species adapted to speciﬁc
hosts, except in the brucellae isolated from marine mammals [14].
Based on the above ﬁndings, information on the biochemical
properties of GadB, an important structural element of GDAR,
may provide useful information to better understand the biology
and the transmission of ‘‘new and atypical’’ brucellae isolated from
the environment and wildlife. It is in fact important to know better
these Brucella species which now include strains isolated from
non-mammals, African frogs [10]. In the present work, the bio-
chemical and spectroscopic properties of BmGadB were compared
with those of the thoroughly characterized EcGadB [1] with which
it shares 73% sequence identity. The level of purity of BmGadB
(>95% as based by SDS–PAGE and spectroscopic measurements)
was essential to carry out a comparison with EcGadB. Similarities
of BmGadB with the E. coli homolog include the hexameric
assembly at acidic pH and the ability to undergo pH-dependent
spectroscopic and activity changes, both affected by chloride ions.
UV–visible and ﬂuorescence emission spectra provide also a clear
indication that at neutral pH the cofactor PLP in the active site of
BmGadB is present as substituted aldamine, thus suggesting that
the reversible inactivation mechanism which was shown to occur
in EcGadB [5,17] is conserved in BmGadB too.
The sequence alignment in Fig. 2 reveals that BmGadB mostly
diverges from EcGadB in the 15–20-amino acids located in the N-
terminal and C-terminal portions, with the notable exception of
residues Ser14, Phe16, Gly17, Pro449, Phe461, His463 and
Thr464. The corresponding residues in the sequence of EcGadB
are Ser16, Phe18 and Gly19, involved in chloride ions binding,
and Pro452, Phe463, His465 and Thr466 belonging to the C-terminal tail involved in active site closure at neutral pH and pro-
viding the residue His465, in the last but one position, which is
responsible for aldamine formation [5,17]. Notably, in BmGadB
two are the candidate histidines for aldamine formation, i.e.
His462 and His463, in the last but two and penultimate position
in sequence, respectively (Fig. 2). At present none of the candidates
can be unequivocally assigned as the one responsible for aldamine
formation. However, as shown in Fig. 2 and based on the multiple
sequence alignment of bacterial Gads (Fig. 1S in [1]), His463 is pro-
posed to be the most likely candidate. Thus His463 should occupy a
position structurally equivalent to His465 in EcGadB, responsible
for locking the active site at pH >5.3 (pH >5.7 in the presence of
chloride ions) [5,17].
As far as the N-terminal region of BmGadB is concerned, it does
not display a propensity to form triple helical bundles at acidic pH.
The formation of these structural elements requires a hydrophobic
core and polar/charged residues on the outside [18]. Furthermore
the residues corresponding to Asp2, Asp8 and Asp15 of EcGadB,
the protonation of which is likely required to drive the formation
of the triple helices at acidic pH, are lacking. In addition a proline
residue in the 7th position is further contrasting the acquisition
of a helical arrangement (Fig. 2). The analysis of the partition of
the protein between the membrane and cytosolic fractions did
not show any effect of acid pH and this is in line with the inability
to form the triple helical bundles. Nonetheless, BmGadB retains the
ability to bind and be affected by chloride ions (Table 2, Figs. 4 and
5), which act as positive allosteric effectors. This is corroborated by
the inspection of the protein sequence in which all the residues
that in the crystal structure of EcGadB were shown to be involved
in halides binding are conserved in BmGadB. Thus the ability of
binding chloride ions (typically abundant in the stomach) is still
possible and is unlinked to the formation of triple helical bundles
in the N-terminal region. The amino acid conservation and the
remarkable similarities of the effect of these anions on EcGadB
and BmGadB (Figs. 4 and 5) is strongly in favor of this hypothesis,
even in the absence of crystal structure [5,18].
The fact that BmGadB is already localized in the membrane frac-
tion at neutral pH still ﬁts with the model of GadB functioning in
acid stress response. In fact even though BmGadB is not signiﬁ-
cantly affected by acidic pH, 30–40% of the total enzyme in the
membrane fraction, regardless of the pH, should be enough to
accomplish the acid protective function. In addition, chloride ions
were found to be very strong allosteric activators of the enzyme.
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modulated by other factors, besides membrane recruitment.
As already pointed out in recent reports on the evolutionary
history of the Brucella genus, which likely occurred as explosive
radiation [38,39], both B. inopinata BO1 and B. inopinata-like BO2
isolated from humans, are amongst the oldest brucellae. Both pos-
sess functional GDAR and their GadB displays full activity [14].
Sequence alignment of GadB from all the Brucella species with a
functional GDAR and available genome sequence, i.e. B. inopinata
BO1, B. inopinata-like BO2, B. ceti, B. pinnipedialis and B. microti,
indicates that B. inopinata BO1 is the most distant (data not
shown). However, none of the amino acid mutations reported in
B. inopinata BO1 (5/464; 1.08%) affects the amino acid residues
constituting the Gad signature or the residues involved in halides
binding. It is therefore likely that GadB from any of the Brucella
species with a functional GDAR shares same spectroscopic, bio-
chemical and functional properties with BmGadB.
To the best of our knowledge, BmGadB and EcGadB are the only
Gad from evolutionary distant bacteria that have been character-
ized in detail, especially with respect to the pH-dependent spectro-
scopic and functional properties important for GDAR. More than
forty years ago interesting biochemical reports on Gad from veg-
etative cells of Clostridium perfringens, an anaerobic Gram-positive
bacterium, belonging to the phylum Firmicutes, were published
[40–44]. However none of the features described for the E. coli
and B. microti homologs were reported. C. perfringens in addition
to being normal inhabitant of the human gut is also a causative
agent of food poisoning in humans. The ability of C. perfringens
vegetative cells and spores to survive from gastric acidity was
investigated in recent years [45]: spores, which are responsible
for the formation of the endotoxin involved in the poisoning symp-
toms, are much less resistant to gastric acidity, unlike vegetative
cells which are still capable of surviving acid stress to a signiﬁcant
extent. Notably C. perfringens possesses both gadB (CPE2058) and
gadC (CPE2060) genes, separated by the gene CPE2059 likely
involved in the protection from acid stress [1]. In light of a possible
involvement of C. perfringens Gad in GDAR and in the successful
colonization of the gut, expression and biochemical studies on this
Gad should be reconsidered.5. Conclusions
The biochemical and spectroscopic properties of BmGadB pro-
vide evidence that GadB, a key component of glutamate-dependent
acid resistance (GDAR) in many new and atypical Brucella species
and in those from marine mammals, shares many features with
the E. coli homolog, EcGadB, which was extensively characterized
at the biochemical and structural level. These features are there-
fore regarded as instrumental for proper functioning of GDAR in
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